Digital Sleep Programs for Preventing Perinatal Depression
(PRISM Trial)
Trial Summary
What is the purpose of this trial?
This trial compares two online sleep programs for pregnant people with insomnia to see if they can prevent depression. One program focuses on changing thoughts and behaviors about sleep, while the other teaches good sleep habits. The program that changes thoughts and behaviors has been shown to be effective in various populations, including shift workers, menopausal women, and cancer survivors.
Do I have to stop taking my current medications?
The trial requires that participants do not take or plan to take antidepressant medication. If you are on antidepressants, you would need to stop taking them to participate.
What data supports the idea that Digital Sleep Programs for Preventing Perinatal Depression is an effective treatment?
The available research shows that Digital Sleep Programs, like Digital Cognitive Behavioral Therapy for Insomnia (dCBT-I), are effective in improving sleep quality and overall well-being. For example, one study found that dCBT-I improved people's health and psychological well-being, and these benefits lasted over time. Another study showed that dCBT-I helped reduce the need for sleep medication and healthcare use. While these studies focus on insomnia, they suggest that improving sleep through digital programs can have positive effects on mental health, which could be beneficial for preventing perinatal depression.12345
What safety data exists for digital sleep programs like dCBT-I?
The research indicates that digital cognitive behavioral therapy for insomnia (dCBT-I) is an effective treatment for insomnia, improving sleep quality, psychological well-being, and quality of life. While the studies focus on efficacy, they do not explicitly mention safety concerns, suggesting that no significant safety issues were reported. The long-term benefits and scalability of dCBT-I further imply a favorable safety profile.12345
Research Team
Jennifer N Felder, PhD
Principal Investigator
University of California, San Francisco
Eligibility Criteria
This trial is for pregnant individuals between 14-28 weeks gestation, aged 18 or older, who have insomnia and access to the internet. They must speak English but can't join if they work night shifts, have other sleep disorders or severe psychiatric conditions like bipolar disorder or active suicidality, are currently majorly depressed, or take antidepressants.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either digital cognitive behavioral therapy for insomnia (CBT-I) or digital sleep hygiene education (SHE) over six weekly online sessions
Follow-up
Participants complete surveys and interviews to monitor outcomes until 1 year postpartum
Treatment Details
Interventions
- Digital CBT-I
- Digital SHE
Digital CBT-I is already approved in United States, European Union for the following indications:
- Insomnia during pregnancy
- Prevention of perinatal depression
- Insomnia during pregnancy
- Prevention of perinatal depression
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
Stanford University
Collaborator